期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Pemafibrate,a potent selective peroxisome proliferator-activated receptorαmodulator,a promising novel treatment for ischemic retinopathy? 被引量:1
1
作者 UCCAODeokhoLee yohei tomita +1 位作者 Kazuno Negishi Toshihide Kurihara 《Neural Regeneration Research》 SCIE CAS CSCD 2023年第7期1495-1496,共2页
Ischemic retinopathy is a retinal disease caused by ischemic attacks.Ischemia is a common pathologic mechanism in various retinal disorders and diseases such as age-related macular degeneration,diabetic retinopathy,gl... Ischemic retinopathy is a retinal disease caused by ischemic attacks.Ischemia is a common pathologic mechanism in various retinal disorders and diseases such as age-related macular degeneration,diabetic retinopathy,glaucoma,or vascular occlusion(Osborne et al.,2004).Although various murine models have been developed to understand a series of metabolic mechanisms induced by retinal ischemia and further used to test promising therapeutics,effective treatment in ischemic retinopathy has not been clearly suggested.This is associated with the notion that the contributing pathologic metabolic pathways might be enormously complex. 展开更多
关键词 RETINOPATHY DEGENERATION
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部